Jiaying Liu

Jiaying Liu

Auto-generated profile, based on publicly available information

Jiaying Liu

Department of Biochemistry and Biomedical Sciences McMaster University Hamilton Canada

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2026 in Advanced Materials
Verified
Journal Article
Open access
SSSurvanshu Saxena
Survanshu Saxena
SLSoyeon Lee
Soyeon Lee
YCYoungeun Choi
Youngeun Choi
JLJonathan L'HEureux‐Hache
Jonathan L'HEureux‐Hache
JLJiaying Liu
Jiaying Liu
LSLeyla Soleymani
Leyla Soleymani
The diagnosis of bacterial infections remains slow because many existing methods rely on enrichment steps such as nucleic acid amplification or growth culture. RNA‐cleaving DNAzymes offer a promising route to accelerate bacterial diagnosis because they can be selected and programmed to specifically recognize disease‐causing bacteria and generate reporter DNA strands for signal readout. However, integrating DNAzymes into biosensors capable of analyzing complex biological matrices remains challenging, as matrix‐associated interferents can destabilize DNAzymes, suppress catalytic activity, and compromise signal detection. Here, we integrate redox RNA‐cleaving DNAzymes housed on antifouling magnetic beads with a lab‐in‐a‐tube platform that incorporates hierarchically structured sensing electrodes within a tubular flow cell for enrichment‐free detection of Clostridioides difficile in stool samples. The combination of antifouling magnetic beads and fluidic replenishment of DNA reporters across the hierarchical electrodes reduces nonspecific binding and enhances reporter capture efficiency, achieving a limit of detection as low as 1.3 × 10 2 CFU mL −1 in buffer. Using an optimized stool‐processing procedure, the sensor enabled detection of C. difficile infection in 38 human stool samples, demonstrating 94.7% concordance with the current gold‐standard polymerase chain reaction method. These results demonstrate a promising platform for enrichment‐free, point‐of‐care diagnosis of infectious diseases in clinic settings.